Intratio
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-06

GERN vs NVCT: stock comparison and AI forecast

Geron Corp (GERN) and Nuvectis Pharma, Inc. (NVCT) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
Nasdaq · Pharmaceutical Preparations

GERN Geron Corp

Market Cap
$610M
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Nasdaq · Pharmaceutical Preparations

NVCT Nuvectis Pharma, Inc.

Market Cap
$579M
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

GERN · NVCT

Key facts

  • GERN and NVCT have similar market capitalizations ($610M and $579M).
  • GERN carries 1.33 times debt per unit of equity, against 0.11 times for NVCT.
  • Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricGERNNVCT
Market Cap$610M$579M
P/B Ratio2.69x4.57x
EPS$-0.10$-1.90
Book Value/Share$0.35$3.89

Profitability & Margins

MetricGERNNVCT
ROE-37.6%-39.8%
ROA-16.2%-35.8%
ROIC-7.1%-41.2%
Operating Margin-15.6%–
Net Margin-41.1%–
EBT Margin-22.6%–

Financial Health

MetricGERNNVCT
Current Ratio6.31x9.92x
Quick Ratio4.61x–
D/E Ratio1.33x0.11x
Financial Leverage2.33x1.11x
Interest Coverage-2.2x–
Working Capital$394M$127M

Cash Flow

MetricGERNNVCT
Operating Cash Flow-$91M-$40M

Income Statement

MetricGERNNVCT
Operating Income-$32M-$52M
Net Income-$85M-$50M
R&D Expense$63M$41M
SG&A Expense$152M–

Dividend & Shareholder Information

MetricGERNNVCT
Shares Outstanding642M33M
FAQ

GERN vs NVCT: stock comparison and AI forecast

Which is bigger, GERN or NVCT?

GERN and NVCT have similar market capitalizations ($610M and $579M).

Which one does Intratio's AI model rank higher, GERN or NVCT?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

Compare

More comparisons

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.